EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors

Joshua J Lingo, Ellen Voigt, Dawn E Quelle

Oncotarget · 2024

DOI: 10.18632/oncotarget.28650 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncotarget, 2024. Verfasst von Joshua J Lingo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, B7-H1 Antigen, Cyclin-Dependent Kinase 4, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein M1B7-H1 AntigenCyclin-Dependent Kinase 4Drug Resistance, NeoplasmHumansAnimalsCyclin-Dependent Kinase 6Protein Kinase InhibitorsMiceMolecular Targeted TherapyNeurofibrosarcomaNerve Sheath Neoplasms

Stichwörter der Autor:innen

CDK4/6-MEK targetingFOXM1MPNSTPD-L1therapy resistance

Substanzen

Forkhead Box Protein M1B7-H1 AntigenCyclin-Dependent Kinase 4FOXM1 protein, humanCD274 protein, humanCyclin-Dependent Kinase 6CDK4 protein, humanProtein Kinase InhibitorsCDK6 protein, human

Autor:innen und Institutionen

  • Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.
  • Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
  • Medical Scientist Training Program, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Lingo, J. J., Voigt, E., & Quelle, D. E. (2024). Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors. Oncotarget. https://doi.org/10.18632/oncotarget.28650

Vancouver

Lingo JJ, Voigt E, Quelle DE. Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors. Oncotarget. 2024. doi:10.18632/oncotarget.28650

BibTeX
@article{Lingo2024,
  author = {Lingo, Joshua J and Voigt, Ellen and Quelle, Dawn E},
  title = {Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors},
  journal = {Oncotarget},
  year = {2024},
  doi = {10.18632/oncotarget.28650}
}
Kostenlos starten →